Rigel Pharmaceuticals Inc. (New) (RIGL) is a publicly traded Healthcare sector company. As of September 21, 2026, RIGL trades at $46.25 with a market cap of $871.23M and a P/E ratio of 2.59. RIGL moved +1.70% today. Year to date, RIGL is +8.90%; over the trailing twelve months it is +32.84%. Its 52-week range spans $15.50 to $52.24. Analyst consensus is buy with an average price target of $65.00. Rallies surfaces RIGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest RIGL news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $46.25 |
| Market Cap | $871.23M |
| P/E Ratio | 2.59 |
| EPS | $17.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.24 |
| 52-Week Low | $15.50 |
| Volume | 269.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $276.79M |
| Net Income | $321.91M |
| Gross Margin | 91.39% |
4 analysts cover RIGL: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $65.00.